Physician profile
Barbara Steplock
NPI 1366701658
$1,855.05
in general payments reported to CMS, 2019-2025
17 companies · $536 in 2025
The $536 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $713 · 2023: $73.43 · 2024: $533 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,131 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,131.27 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $443.71 | 2022-2023 | |
| Actelion Pharmaceuticals US, INC. | $427.51 | 2024-2025 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $364.52 | 2022-2025 | Verquvo, Winrevair, Januvia |
| Novartis Pharmaceuticals Corporation | $123.52 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $91.99 | 2022 | |
| Janssen Biotech, INC. | $64.61 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $52.98 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $46.12 | 2024 | Wainua, Farxiga |
| Abiomed | $45.39 | 2024-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $34.79 | 2025 | Eliquis, Camzyos |
| Regeneron Healthcare Solutions, INC. | $30.60 | 2022 | |
| Intercept Pharmaceuticals, INC. | $28.37 | 2022 | |
| Viatris Specialty LLC | $25.53 | 2025 | Yupelri |
| Celgene Corporation | $24.56 | 2022 | |
| Genzyme Corporation | $23.13 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $13.97 | 2024 | Injectafer |
| Alnylam Pharmaceuticals INC. | $13.75 | 2024 | Amvuttra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Steplock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.